JP2024532489A5 - - Google Patents
Info
- Publication number
- JP2024532489A5 JP2024532489A5 JP2024513973A JP2024513973A JP2024532489A5 JP 2024532489 A5 JP2024532489 A5 JP 2024532489A5 JP 2024513973 A JP2024513973 A JP 2024513973A JP 2024513973 A JP2024513973 A JP 2024513973A JP 2024532489 A5 JP2024532489 A5 JP 2024532489A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- sequence shown
- binding protein
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021902832A AU2021902832A0 (en) | 2021-09-01 | Methods and compositions for stimulating immune activity | |
| AU2021902832 | 2021-09-01 | ||
| PCT/AU2022/051066 WO2023028653A1 (en) | 2021-09-01 | 2022-09-01 | Novel dysfunctional p2x7 binders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532489A JP2024532489A (ja) | 2024-09-05 |
| JP2024532489A5 true JP2024532489A5 (enExample) | 2025-08-01 |
Family
ID=85410590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513926A Pending JP2024532482A (ja) | 2021-09-01 | 2022-09-01 | 免疫活性を刺激するための方法および組成物 |
| JP2024513973A Pending JP2024532489A (ja) | 2021-09-01 | 2022-09-01 | 新規の機能不全ｐ２ｘ７結合剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513926A Pending JP2024532482A (ja) | 2021-09-01 | 2022-09-01 | 免疫活性を刺激するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240368282A1 (enExample) |
| EP (2) | EP4395814A4 (enExample) |
| JP (2) | JP2024532482A (enExample) |
| CN (2) | CN117813109A (enExample) |
| AU (2) | AU2022341030A1 (enExample) |
| CA (2) | CA3223079A1 (enExample) |
| MX (2) | MX2023015469A (enExample) |
| WO (2) | WO2023028657A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016100232A1 (en) * | 2014-12-15 | 2016-06-23 | The Regents Of The University Of California | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 |
| CA3195512A1 (en) * | 2020-10-14 | 2022-04-21 | Vahe Bedian | Compositions and methods for treatment of thyroid eye disease |
| JP2024531151A (ja) | 2021-08-10 | 2024-08-29 | ビリジアン セラピューティクス， インコーポレイテッド | 甲状腺眼疾患の処置のための組成物、用量および方法 |
| JP2026507807A (ja) * | 2023-03-08 | 2026-03-06 | バイオセプター （オースト） プロプライエタリー・リミテッド | 機能不全ｐ２ｘ７受容体に結合するためのキメラ抗原受容体 |
| WO2024211413A2 (en) * | 2023-04-05 | 2024-10-10 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Trogocytosis in cancer cells and methods for treating cancer related thereto |
| WO2024220870A1 (en) * | 2023-04-19 | 2024-10-24 | The University Of Chicago | Antibody-targeted enzymatic chemoprotection |
| KR20260024373A (ko) * | 2023-05-05 | 2026-02-20 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 다중-수용체 자연 살해 세포 |
| WO2025000037A1 (en) * | 2023-06-30 | 2025-01-02 | Biosceptre (Aust) Pty Ltd | Molecules and methods for activating car t cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3395832B1 (en) * | 2009-08-20 | 2021-11-24 | Biosceptre (Aust) Pty Ltd | Anti p2x7 receptor antibodies and fragments thereof |
| EP2516470B1 (en) * | 2009-12-24 | 2018-02-07 | Biosceptre (Aust) Pty Ltd | Antibodies to non-functional oligomeric p2x7 receptors |
| CN107614528A (zh) * | 2015-04-02 | 2018-01-19 | 生物权威（英国）有限公司 | 疼痛治疗 |
| US12121539B2 (en) * | 2015-09-11 | 2024-10-22 | Biosceptre (Aust) Pty Ltd | Chimeric antigen receptors and uses thereof |
| CN109862883A (zh) * | 2016-10-21 | 2019-06-07 | 生物权威（英国）有限公司 | 细胞毒性颗粒 |
| AU2019275479B2 (en) * | 2018-05-21 | 2022-12-08 | Biosceptre (Aust) Pty Ltd | Chimeric antigen receptors with modified linker domains and uses thereof |
| WO2020191344A1 (en) * | 2019-03-20 | 2020-09-24 | The Regents Of The University Of California | Claudin-6 bispecific antibodies |
| MX2021011750A (es) * | 2019-03-27 | 2021-12-10 | Nat Res Council Canada | Anticuerpos anti-egfrviii y fragmentos de union a antigenos de los mismos. |
| CA3211323A1 (en) * | 2021-03-11 | 2022-09-15 | Patrick Schlegel | Novel cell therapy system |
-
2022
- 2022-09-01 JP JP2024513926A patent/JP2024532482A/ja active Pending
- 2022-09-01 MX MX2023015469A patent/MX2023015469A/es unknown
- 2022-09-01 EP EP22862431.8A patent/EP4395814A4/en active Pending
- 2022-09-01 WO PCT/AU2022/051070 patent/WO2023028657A1/en not_active Ceased
- 2022-09-01 CA CA3223079A patent/CA3223079A1/en active Pending
- 2022-09-01 JP JP2024513973A patent/JP2024532489A/ja active Pending
- 2022-09-01 EP EP22862427.6A patent/EP4395813A4/en active Pending
- 2022-09-01 CN CN202280053364.9A patent/CN117813109A/zh active Pending
- 2022-09-01 US US18/688,086 patent/US20240368282A1/en active Pending
- 2022-09-01 CN CN202280059679.4A patent/CN117881421A/zh active Pending
- 2022-09-01 US US18/686,554 patent/US20240376193A1/en active Pending
- 2022-09-01 CA CA3223086A patent/CA3223086A1/en active Pending
- 2022-09-01 AU AU2022341030A patent/AU2022341030A1/en active Pending
- 2022-09-01 AU AU2022335932A patent/AU2022335932A1/en active Pending
- 2022-09-01 MX MX2023015028A patent/MX2023015028A/es unknown
- 2022-09-01 WO PCT/AU2022/051066 patent/WO2023028653A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021510521A5 (enExample) | ||
| JP2021508469A5 (enExample) | ||
| JP7543247B2 (ja) | ヒトＴｉｍ－３に対するモノクローナル抗体 | |
| JP2023549537A5 (enExample) | ||
| JP2021533159A5 (enExample) | ||
| JP2023516004A5 (enExample) | ||
| EP4155320A1 (en) | Anti-b7h4 antibody, and bispecific antibody and use thereof | |
| US10836833B2 (en) | Cell engaging binding molecules | |
| JP2021525806A5 (enExample) | ||
| JP2021511387A5 (enExample) | ||
| AU2019229663A1 (en) | PD1 binding agents | |
| JP2023516941A5 (enExample) | ||
| JP2026027248A (ja) | 抗原結合分子およびその使用 | |
| JP2025511288A (ja) | 抗ｐｖｒｉｇ抗体、その医薬組成物及びその使用 | |
| JP2022521305A (ja) | 抗ｐｄ－ｌ１抗体及びその使用 | |
| JP2024533457A5 (enExample) | ||
| JP2022520632A (ja) | 共通軽鎖を含む抗体及びその使用 | |
| JP2022548881A5 (enExample) | ||
| WO2020132654A1 (en) | Antagonist antibodies against human immune checkpoint ceacam1 (cd66a) and formulations, kits, and methods of use thereof | |
| JP7641292B2 (ja) | 抗ｃｄ１９抗体、その使用方法及び製造方法 | |
| JP2023536630A5 (enExample) | ||
| JP2023550446A5 (enExample) | ||
| WO2025024780A1 (en) | Antibodies that bind gamma-delta t cell receptors for the treatment of cancer | |
| EP4183800A1 (en) | Novel sars-cov-2 neutralizing antibodies | |
| HK40104915A (en) | Multispecific antibodies targeting cdh17-expressing tumors and method of making and using thereof |